Blog
RSS FeedPosted by Michael Wonder on 30 Aug 2024
Public Summary Documents – May 2024 PBAC meeting
30 August 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2024 PBAC ...
Posted by Michael Wonder on 30 Aug 2024
Agenda for the September 2024 PBAC intracycle meeting
30 August 2024 - The agenda for the September 2024 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 28 Aug 2024
Life prolonging breast cancer drug receives expanded access on the PBS
28 August 2024 - Australians diagnosed with a type of metastatic breast cancer will now have access to a life ...
Posted by Michael Wonder on 25 Aug 2024
Vulnerable Aussies may remain unprotected against severe RSV
24 August 2024 - There are mounting concerns that Australians at greatest risk of severe respiratory syncytial virus will miss ...
Posted by Michael Wonder on 25 Aug 2024
Recommendations made by the PBAC – July 2024
23 August 2024 - Recommendations made by the PBAC in July 2024 relating to the listing of medicines on the ...
Posted by Michael Wonder on 24 Aug 2024
Breast cancer sufferer Brandi Allsop needs costly treatment for a chance to stay alive
23 August 2024 - A young Hervey Bay mother fighting to access costly treatment for her stage three breast cancer has ...
Posted by Michael Wonder on 19 Aug 2024
Update from the PBAC (August 2024)
19 August 2024 - An update from the Deputy Chair of the PBAC. ...
Posted by Michael Wonder on 19 Aug 2024
New PBS listing for migalastat (Galafold) for the treatment of Fabry disease
19 August 2024 - On 1 September 2024, migalastat hydrochloride (Galafold) will become available on the PBS for the treatment ...
Posted by Michael Wonder on 19 Aug 2024
Most expensive treatments remain out of reach without health reform
18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has ...
Posted by Michael Wonder on 12 Aug 2024
Cheaper medicines for rare genetic disorders and cancer
12 August 2024 - Adults with hereditary transthyretin-mediated amyloidosis and with certain cancers, will now have access to cheaper medicines ...
Posted by Michael Wonder on 06 Aug 2024
PBS listing for Australians with hereditary transthyretin-mediated amyloidosis with polyneuropathy
1 August 2024 - Medison Pharma, alongside their partner Alnylam Pharmaceuticals, are pleased to announce that from 1 August 2024, ...
Posted by Michael Wonder on 04 Aug 2024
Groundbreaking therapy for terminal cancers finally publicly funded
2 August 2024 - A groundbreaking pan-tumour pharmaceutical that can act upon multiple different tumour types has been publicly funded ...
Posted by Michael Wonder on 04 Aug 2024
Agenda for the November 2024 PBAC meeting (version 1)
31 July 2024 - The agenda for the November 2024 PBAC meeting is now available. ...
Posted by Michael Wonder on 01 Aug 2024
Life-changing cancer treatment jab added to PBS
31 July 2024 - Australians fighting lung and liver cancer will soon be able to access a life-saving cancer treatment ...
Posted by Michael Wonder on 01 Aug 2024
Schedule of Pharmaceutical Benefits - 1 August 2024
1 August 2024 - The August 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...